Houston Chronicle Sunday

Long COVID patients see more gastro issues

- By Pam Belluck

Stomach pain, constipati­on, diarrhea, vomiting, bloating — these are symptoms frequently reported by people with long COVID.

Now a large new study reports that COVID patients were significan­tly more likely to experience gastrointe­stinal problems a year after infection than people who were not infected.

The study, published Tuesday in the journal Nature Communicat­ions, compared medical records of 154,068 COVID patients in the Veterans Health Administra­tion system with about 5.6 million patients of similar age and other characteri­stics who had not contracted the coronaviru­s. COVID patients were 36 percent more likely to have long-term gastrointe­stinal problems that they did not have before their infection, with 9,605 of them experienci­ng issues affecting the digestive system, intestines, pancreas or liver.

The most common diagnoses were acid-related disorders, like gastroesop­hageal reflux disease (known as GERD) and peptic ulcer disease, which were identified in more than 2,600 patients.

“There seems to be some dysregulat­ion that

points to a major imbalance in acid production,” said the senior author of the study, Dr. Ziyad AlAly, chief of research and developmen­t at the VA St. Louis Health Care System and a clinical public health researcher at Washington University in St. Louis.

Serious inflammato­ry illnesses — like acute pancreatit­is and cholangiti­s, which is inflammati­on of the bile duct system — affected a much smaller percentage of patients, but they were nonetheles­s more common among those who had COVID than those who did not.

“With all of these disorders, there is an increased odds ratio, meaning that the people who had COVID and survived for 30

days or longer were more at risk of each of these categories,” said Dr. Saurabh Mehandru, a professor of gastroente­rology at the Icahn School of Medicine at Mount Sinai in New York who was not involved in the study.

Long COVID patients were also at higher risk of gastrointe­stinal symptoms, the most common being constipati­on, abdominal pain and diarrhea.

The study, like others drawing on the database of veterans, involves a patient population that is largely white and male with an average age of about 61. Still, the same patterns were seen among the study’s 37,000 postCOVID Black patients and nearly 17,000 postCOVID

female patients, Al-Aly said.

The patients became infected during the pandemic’s early waves, testing positive for the coronaviru­s between March 1, 2020, and Jan. 15, 2021, the overwhelmi­ng majority before vaccines were available. Al-Aly and Mehandru noted that the experience might be different for people infected more recently. Newer virus variants might have different effects, they said, and some research suggests that vaccines can reduce the risk of various long COVID symptoms.

There are several reasons coronaviru­s infections may fuel long-term gastrointe­stinal problems. Mehandru, who has studied some possible causes, said his team and others had found that a protein the virus attaches to on some cell surfaces, called the ACE2 receptor, was abundant in the lining of the small intestine. Those receptors might provide a way for the virus to directly enter the digestive system, he said. It’s also possible that some viral fragments remained after infections resolved, keeping patients’ immune systems activated and generating inflammati­on-related symptoms.

Another possibilit­y is the “gut-brain connection,” said Mehandru, explaining that “when we’re stressed, we have intestinal manifestat­ions.” And, he added, “some of the symptoms could also be because of a generalize­d state of being unwell or having illness outside of the intestines, which could impact how we move our bowels or mean that we feel bloated or have acid reflux.”

Al-Aly said most long COVID patients had other symptoms besides gastrointe­stinal problems, suggesting that the condition was “too complex to have just one mechanism that explains all of it.”

The new study did not identify whether certain previous health conditions, like diabetes or cardiovasc­ular disease, put people at greater risk of post-COVID gastrointe­stinal problems. Like many other long COVID studies, it did find that people whose initial infections were severe enough to warrant intensive care or other hospitaliz­ation were more prone to long-term symptoms. Still, people with mild initial infections — who make up a majority of COVID patients — were nonetheles­s at greater risk than people who were not infected.

Underscori­ng the significan­ce of post-COVID symptoms, the study found that long COVID patients were at greater risk of gastrointe­stinal problems than nearly 6 million people in the veterans database before the pandemic. It also found that people hospitaliz­ed with a coronaviru­s infection were more likely to develop long-term gastrointe­stinal issues than people hospitaliz­ed with the flu.

Al-Aly did sound one note of optimism. While some symptoms of long COVID, like fatigue and brain fog, can be intractabl­e for months despite different therapies, many gastrointe­stinal symptoms are treatable.

“Obviously, there’s no one treatment for all of this,” he said. “But I think these are diagnoses and signs and symptoms that could be managed.”

 ?? Minami Tokuyama//MehandruLa­b at the Icahn School of Medicine at Mount Sinai/NYT ?? ACE2, the receptor for the virus that causes COVID-19, is shown in green, with intestinal epithelial cells in red and cell nuclei in blue. A study found that those who had COVID were 36% more likely to have gastrointe­stinal problems a year later.
Minami Tokuyama//MehandruLa­b at the Icahn School of Medicine at Mount Sinai/NYT ACE2, the receptor for the virus that causes COVID-19, is shown in green, with intestinal epithelial cells in red and cell nuclei in blue. A study found that those who had COVID were 36% more likely to have gastrointe­stinal problems a year later.

Newspapers in English

Newspapers from United States